drugset / Trial / NCT00034606
Comparing 3 Schedules of Alimta Plus Gemzar
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of the study is to measure tumor response rates for three schedules of Alimta(LY231514) in combination with gemcitabine in patients with locally advanced or metastatic non small cell lung cancer who have received no prior chemotherapy regimen.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pemetrexed | Small molecule | — | — |
| Background | Gemcitabine | Small molecule | — | — |